Department of Pharmaceutics, Faculty of Pharmacy, Al-Arab Medical University, Benghazi, Libya.
Libyan J Med. 2010 Oct 21;5. doi: 10.3402/ljm.v5i0.5440.
Medicines are health technologies that can translate into tangible benefits for numerous acute as well as chronic health conditions. A nation's pharmaceutical sector needs to be appropriately structured and managed in order to ensure a safe, effective and quality supply of medicines to society. The process of medicines management involves the sequential management of five critical activity areas; namely; registration, selection, procurement, distribution and use. Formalized and standardized management of all five critical activity areas positively influences the availability, quality and affordability of medicines and ultimately increases the reliability and quality of the national healthcare system.
The aim of this review is to examine the current structure and operation of medicines management (i.e. the pharmaceutical sector) in Libya.
In the Libyan healthcare system all five critical activity areas are compromised. Restructuring of the pharmaceutical sector in Libya is required in order to provide and sustain sound pharmaceutical services for Libyan society and improve the national public health outcomes.
药品是可将众多急性和慢性健康状况转化为切实利益的卫生技术。一个国家的制药部门需要进行适当的构建和管理，以确保向社会安全、有效和高质量地供应药品。药品管理过程涉及五个关键活动领域的连续管理；即注册、选择、采购、配送和使用。对所有五个关键活动领域进行正式和标准化管理，会积极影响药品的供应、质量和可负担性，并最终提高国家卫生保健系统的可靠性和质量。
本文旨在检查利比亚药品管理（即制药部门）的现行结构和运作情况。
在利比亚的医疗保健系统中，所有五个关键活动领域都受到了影响。利比亚需要对制药部门进行重组，以便为利比亚社会提供和维持健全的药品服务，并改善国家公共卫生成果。
